|
|
||||||||
1 Unit of Environmental Epidemiology, National Public Health Institute, Kuopio, Finland. 2 Harvard School of Public Health, Boston, MA, USA. 3 Dept of Occupational and Environmental Medicine, University Hospital, Lund, Sweden. 4 Environmental and Occupational Health Unit, University of Utrecht, Utrecht, The Netherlands
CORRESPONDENCE: B. Brunekreef, Institute for Risk Assessment Sciences, Environmental and Occupational Health Group, PO Box 80176, 3508 TD, Utrecht, The Netherlands. Fax: 31 302535077. E-mail: b.brunekreef@iras.uu.nl
Keywords: atopy, children, lung function, respiratory symptom
Received: October 6, 2000
Accepted October 16, 2001
This study was funded in the framework of the Commission of the European Communities Environment Programme, contracts EV5V-CT92-0220, CIPD-CT-92-5052 and ERBCIPD-CT-93-0046. K.L. Timonen was supported by grants from The Finnish Anti-Tuberculosis Association Foundation and The Ida Montin Foundation. The Finnish, Norwegian and two Swedish centres were funded by grants from the respective Governments.
| Abstract |
|---|
|
|
|---|
Children with chronic respiratory symptoms, living in 10 European countries, were selected from a parent-completed questionnaire (n=4,307). Atopy was measured with skin-prick tests, and lung function with spirometry. A total of 1,854 (86% of those in the initial cohort) children kept a successful daily diary regarding their respiratory symptoms for 23 months.
In multivariate logistic regression analyses, children with asthmatic symptoms, particularly those with doctor-diagnosed asthma, had a greater risk of occurrence of lower respiratory symptoms (odds ratio (OR): 6.12; 95% confidence interval (CI): 4.998.35) than children with a dry nocturnal cough as their only symptom. Atopy, particularly a positive reaction to indoor allergens, was significantly associated with occurrence of lower respiratory symptoms. For atopy the OR was 1.62 (95% CI: 1.341.96). A reduced level of maximal mid-expiratory flow was associated with an increased risk of lower respiratory symptoms, cough and phlegm. The associations were similar in Scandinavia, Central Eastern, Western and Southern Europe.
To conclude, asthmatic symptoms reported in a questionnaire, atopic status and a reduced level of maximal mid-expiratory flow were associated with the occurrence of acute respiratory symptoms, especially those of lower respiratory symptoms.
School-aged children often experience acute respiratory symptoms. However, few studies have examined the longitudinal relationship between host factors, such as atopy and lung function, and respiratory morbidity in children. Among these are the studies carried out in Southampton, UK 1, 2. In these studies, children with either wheeze or cough were followed-up over a year, by daily diaries. The main conclusion was that, although both atopy and symptoms of wheeze were associated with respiratory morbidity, a pre-existing doctor-diagnosis of asthma was the strongest predictive factor associated with more frequent and more severe lower respiratory symptom episodes, a greater proportion of symptomatic days, and a greater overall peak flow variability.
Previously, it has been shown among children from the 10 European countries that, compared with children for whom only dry nocturnal cough was reported in the screening questionnaire, children with asthmatic symptoms had a greater diurnal and day-to-day variation in peak expiratory flow (PEF) during a 23 month follow-up. Moreover, atopy, especially positive reactions to indoor allergens, and a reduced level of lung function were also predictors of a greater variation in PEF 3. Therefore, the aim of the present study was to investigate whether these characteristics would also be associated with occurrence of acute respiratory symptoms during a 23 month, daily follow-up in this population.
| Subjects and methods |
|---|
|
|
|---|
Study design
In each centre there were two panels of children with chronic respiratory symptoms: an urban and a suburban, or rural, panel. The children were selected by a screening questionnaire that was completed by the parents of the child. During autumn 1993 and winter 1994, the children were characterized with skin-prick tests and spirometric lung function measurements. During winter 19931994, the children kept, with the help of their parents, a daily diary on respiratory symptoms, and measured PEF every morning and evening for 3 months 4, 5.
Subjects
Of a total of 4,307 children aged 612 yrs eligible to enter the study and asked to participate, 2,112 (49%) children were characterized with skin-prick test and spirometric lung function measurements. A total of 2,152 children started keeping the diary on respiratory symptoms and measuring daily PEF. Of these, 1,854 (86%) children had valid symptoms and PEF data on more than 60% of the days, and these children were included in the present analyses (table 1
). A total of 30% of the children had complete diary data, and 55% of the children had data on 8099% of the days. A detailed description of the panels has been published previously 3.
|
Skin-prick tests
In all centres, skin-prick tests were done using the ALK skin-prick test allergen panel (ALK Laboratories, Horsholm, Denmark). The allergens tested in all centres were birch (Betula verrucosa) and timothy grass (Pheleum pratense) pollens, cat fur (Felis catus), and house dust mite (Dermatophagoides pteronyssinus) 4, 5. Histamine hydrochloride (10 mg·mL1) and glycerol (50%) were used as positive and negative controls, respectively. In addition, two local allergens were tested in each centre: dog epithelial dander and Cladosporium in Amsterdam, Oslo, Umeå and Malmö, dog epithelial dander and mugwort pollen in Kuopio, alternaria and plantago in Berlin, alternaria and ragweed in Budapest, alternaria and parietaria in Pisa, olive and parietaria in Athens, grass mix pollens and dog epithelial dander in Cracow and Katowice, and grass mix pollens and mould mix in Prague and Teplice. A mean weal diameter of >2 mm was regarded as a positive result 4, 5. If there was no reaction to the positive control or a reaction >1 mm to the negative control, the results were excluded from the analyses (n=121).
Lung function tests
The spirometric lung function measurements were performed according to the recommendations of the European Community for Coal and Steel 46. All spirometric results were corrected to body temperature, atmospheric pressure and saturation with water vapour. Predicted values based on sex and height of the subjects were calculated according to Zapletal (see 7).
Symptom diaries
The children were followed-up for 23 months during winter 19931994. They kept a daily diary on respiratory symptoms with the help of their parents. The following symptoms were reported: cough, phlegm, runny or stuffed nose, shortness of breath, wheeze, attack(s) of shortness of breath with wheeze, and sore throat. In addition, the children measured their PEF rate every morning and evening 4, 5. Results of PEF measurements have been published elsewhere 3.
Definitions
Children who had suffered from wheezing or attacks of shortness of breath with wheezing during the previous 12 months were defined as having "asthmatic symptoms". Children who had either these asthmatic symptoms and/or doctor-diagnosed asthma were defined as having "asthma". Children who did not have "asthma", but who had reported dry cough at night that was not associated with colds, were defined as having "cough alone". "Atopy" was defined as having at least one positive reaction in skin-prick tests. "Lower respiratory symptom" was defined as being present when the child reported in the diary, on a given day to have at least one of the following symptoms: shortness of breath, wheeze, or attacks of shortness of breath with wheeze. "Upper respiratory symptom" was defined as being present when the child reported in the diary to have a sore throat, or a runny or stuffed nose.
To study possible area differences within Europe, four regions were defined. The Finnish, Swedish and Norwegian centres formed "Scandinavia", the Polish, Czech and Hungarian centres formed "Central Eastern Europe", the German and Dutch centres formed "Western Europe", and the Italian and Greek centres formed "Southern Europe".
Statistical analyses
For each child, the proportion of the days a symptom was reported to be present was calculated from the total number of days on which there was a valid report for that symptom. Days with a missing value for the symptom were excluded from the total number of days. Multivariate logistic regression analyses were performed using the GENMOD procedure, which allowed for the calculation of an over- or under-dispersion parameter, and incorporation of it in the estimation of the standard errors of the variables 8.
In all models, adjustments were made for sex, age and study centre. In addition, when studying the effects of chronic respiratory symptoms reported in the screening questionnaire, adjustments were also made for atopy and level of lung function as maximal mid-expiratory flow (MMEF) (% from predicted). Similarly, when studying the effects of skin-prick test results, the models were also adjusted for chronic symptom status (having asthma or not) and level of lung function. Reactivity to house dust mite, cat and pollen allergens were included in the statistical model at the same time, to study the independent effects of these allergens. When studying the effects of spirometric lung function, adjustments were also made for atopy and chronic symptom status. The results are given as odds ratios (OR) with 95% confidence intervals (CI).
| Results |
|---|
|
|
|---|
|
|
|
The risk of lower respiratory symptoms rose as the number of positive reactions in the skin-prick test increased (fig. 2
). The relationship between the number of positive reactions in the skin-prick test and other symptoms was less strong.
|
|
| Discussion |
|---|
|
|
|---|
The effect estimates in the present study, however, may be too small. This is because, in the statistical models used, there were always variables for prior symptom status, level of lung function and reactivity to skin-prick tests. These factors are not, however, independent of each other. Therefore, by having all of these factors controlled for, the effects could have been underestimated.
Chronic respiratory symptoms reported in the screening questionnaire were associated with the occurrence of acute respiratory symptoms during the 23 month, daily follow-up, especially the occurrence of lower respiratory symptoms. Compared to children with cough alone, children with asthma experienced lower and upper respiratory symptoms, and phlegm more often. The difference in reported cough during the follow-up was not so clear. Only children with both asthmatic symptoms during the past 12 months and doctor-diagnosed asthma reported cough more often than children with cough alone. In contrast to the study by Pattemore et al. 2, recent asthmatic symptoms were a better predictor of acute symptoms than a doctor's diagnosis of asthma. However, children with both the diagnosis and asthmatic symptoms experienced acute respiratory symptoms most often.
A similar pattern for the occurrence of respiratory symptoms has been observed in previous studies. Peat et al. 9 initially studied a cohort of children with current asthma, wheeze only, or who were normal. Current asthma was defined as having both recent wheeze, assessed by a questionnaire, and bronchial hyperresponsiveness, assessed by a histamine challenge test. During the follow-up over a year, most children (93%) in the group of current asthma had wheeze, which was clearly more than among children in the wheeze-only group (52%). However, the latter group demonstrated more wheeze than the children in the normal group (18%). Among 650 children followed-up prospectively for 2 yrs. Children for whom current persistent wheeze was reported at the initial interview experienced more lower respiratory illness than children without current persistent wheeze at the initial interview 10. In contrast, no significant difference was found for upper respiratory illness. Clough et al. 1 studied children with wheeze or cough only, and with or without atopy. The symptom of wheeze was associated with a significantly greater severity of acute respiratory symptoms, but not with a greater proportion of days with lower respiratory tract symptoms, compared with cough as observed in the present study. Furthermore, unlike this study no interaction between atopy and wheeze was shown.
In the subject selection phase of the study, one-half of the children asked, agreed to participate. This is a little less than in the follow-up study of Pattemore et al. 2 in which the response was 62%. It is possible that children, who had had more respiratory symptoms, would have been more likely to participate in the study. However, this selection would have led to more symptomatic children in all groups. Therefore, it is unlikely that the initial selection of subjects would have led to overestimation of the effects. In addition, if children with less severe chronic respiratory symptoms, e.g. cough alone, were less motivated to fill in the diary when free of symptoms, the proportion of days with acute respiratory symptoms would have been overestimated. This would lead to attenuation in the difference between children with asthma and with cough alone. In the present study, this is not likely. A child had to have >60% of the days with valid data to be included in the analyses. Moreover, there was no difference in the total number of reporting days between children having asthma and children with cough alone.
Atopy, and especially a positive reaction to house dust mite and cat were significantly associated with the occurrence of lower respiratory symptoms. These results are supported by previous studies. In their study among children with cough or wheeze, Clough et al. 1 demonstrated that when controlling for the symptom of wheeze, atopy was associated with a significantly greater proportion of days with symptoms than the absence of atopy, during a follow-up over a year. Henderson et al. 11 examined correlates of recent wheezing episodes in a case-control study among children. In that study, sensitization to house dust mite was consistently associated with recurrent wheezing episodes, with an OR of 5.2 (95% CI: 3.09.0), whereas no evidence that pollen allergy contributed significantly to susceptibility to recurrent wheezing episodes was provided.
Previously, it has been stated that sensitivity to house dust mite and to cat dander is closely associated with current asthma in children, whereas grass sensitivity is not a significant independent risk factor for asthma 12. This was further supported by the present study. These results confirm the important role indoor allergens play in the occurrence of asthmatic symptoms. However, since this study was confined to the winter time, when children were little exposed to pollen, a role for pollen in the occurrence of acute respiratory symptoms cannot be ruled out.
There was no clear pattern in the association between the level of FVC and the occurrence of acute respiratory symptoms. A reduced level in FEV1 was positively associated with the occurrence of respiratory symptoms, but was significant only with the occurrence of phlegm. A low level of FEV1/FVC was significantly associated with lower respiratory symptoms as well as phlegm. Conversely, a reduced level of MMEF was significantly associated with lower respiratory symptoms, cough and phlegm. This finding together with the previous results, in which a reduced level of MMEF was closely associated with asthmatic symptoms, positive reactions to indoor allergens, and a greater PEF variability, supports MMEF as a sensitive parameter of airway obstruction 13. MMEF is effort independent and measures flow predominantly in the peripheral airways, whereas FEV1 measures airflow predominantly in the central airway. Therefore, MMEF might be reduced while asymptomatic or in an earlier stage than FEV1.
It is noteworthy that in addition to the level of lung function, positive reactions to house dust mite and cat, and a doctor-diagnosis of asthma with symptoms in the past 12 months were also strongly associated with phlegm in this study. Phlegm is not a classical asthmatic symptom, but clearly in this study, it responds to the same risk factors as more traditional symptoms like wheezing.
The present multicentre study is the first focused on associations between chronic respiratory symptoms, skin test results and lung function, and acute respiratory morbidity in different European regions. In all four regions, the associations between chronic respiratory symptoms, atopy, lung function and acute respiratory morbidity were similar among symptomatic children. To conclude, asthmatic symptoms (reported in a questionnaire), atopy (especially a positive reaction to house dust mite and cat), and a reduced level of maximal mid-expiratory flow were associated with the occurrence of acute respiratory symptoms specifically lower respiratory symptoms, during the 23-month follow-up.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |